W. De Backer (Antwerp, Belgium), G. Mwenge (Brussels, Belgium), A. Valipour (Vienna, Austria), M. Alahmari (London, United Kingdom)
Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure
M. Hobzova, E. Sovova, D. Stejskal, V. Kolek, J. Zapletalova, M. Sova (Prostejov, Czech Republic)
|  |
Evaluation of renal function in a cohort of patients affected by obstructive sleep apnea
P. Pozzi, S. Marelli, G. Tripepi, C. Zoccali, L. Ferini Strambi (Milan, Reggio Calabria, Italy)
| |
Treatment of central sleep apnea in patients with heart failure: A retrospective observational study
G. de Vries, P. Meijer, T. Blijham, H. Kerstjens, P. Wijkstra (Groningen, Netherlands)
| |
Obstructive sleep apnea in patients with typical atrial flutter: Clinical, prognostic and therapeutic implications
N. Grau, V. Bazan, E. Valles, M. Félez, C. Sanjuás, M. Cainzos, B. Benito, J. Gea, J. Bruguera, J. Martí (Barcelona, Spain)
| |
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
E. Nena, P. Steiropoulos, A. Tzouvelekis, N. Papanas, G. Zacharis, K. Archontogeorgis, M. Kouratzi, A. Koulelidis, P. Boglou, M. Froudarakis, D. Bouros (Alexandroupolis, Greece)
| |
Relationship between upper airway inflammation and systemic inflammation in obstructive sleep apnoea
E. Vicente, C. Salvador, P. Ventura, P. Cubero, L. Madre, M. Forner, J. M. Marin (Zaragoza, Spain)
| |
Osteoprotegerin, body composition and cardiovascular risk in sleep apnea syndrome
M. Kosacka, A. Korzeniewska, R. Jankowska (Wroclaw, Poland)
| |
Clinical parameters and biomarkers for the early detection of impaired glucose tolerance in OSA patients
R. Cherneva, O. Georgiev, D. Petrova, A. Cakova, V. Lozanov, V. Mitev (Sofia, Bulgaria)
|  |
The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study
O. C. Deleanu, A. E. Malaut, S. Mihaicuta, R. Ulmeanu, F. D. Mihaltan (Bucharest, Timisoara, Romania)
| |
Left ventricular function assessment in patients with obstructive sleep apnea syndrome
R. Bakr, R. Elwahsh, M. Ahmed, R. Yaseen (Shebin Elkom, Egypt)
| |
Serum aminotransferase levels in patients with severe obstructive sleep apnea
N. Kiapour, P. Adimi, F. Soltani, Z. Mohammad Taheri, N. Fayazi (Tehran, Islamic Republic Of Iran)
| |
The correlation of echocardiographic findings with BNP, blood uric acid and CPR in OSAS patients with manifest right cardiac pathologies
O. Araz, E. Yilmazel Ucar, H. Degirmenci, D. Pulur, M. Gorguner, M. Akgun (Erzurum, Turkey)
| |
Visceral fat in non-to-moderate and severe obstructive sleep apnoea
Y. Harada, T. Oga, K. Murase, Y. Toyama, K. Aihara, Y. Chihara, C. Yoshimura, T. Hitomi, T. Handa, T. Tsuboi, M. Mishima, K. Chin (Kyoto, Japan)
| |
The inflammation and insulin resistance in obstructive sleep apnea
E. Bulcun, M. Ekici, U. Kisa, A. Ekici (Kirikkale, Turkey)
| |
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
M. Targowska, R. Plywaczewski, L. Jonczak, A. Czyzak-Gradkowska, P. Sliwinski (Warsaw, Poland)
| |
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
R. Plywaczewski, M. Targowska, A. Czyzak-Gradkowska, L. Jonczak, P. Bielen, D. Gorecka, P. Sliwinski (Warsaw, Poland)
| |
Left and right ventricular function in obstructive sleep apnea patients: Echocardiographic speckle tracking strain analysis of CPAP therapy effects
B. Lamia, S. Gelinotte, F. Portier, L.C. Molano, C. Tardif, A. Cuvelier, J.F. Muir (Rouen, France)
| |
Neutrophil ROS production in obese and non-obese men with different severity of obstructive sleep apnoea
G. Pilkauskaite, S. Miliauskas, S. Lavinskiene, R. Sakalauskas (Kaunas, Lithuania)
| |
Relationship between sleep apnea syndrome, plasma myeloperoxidase levels and cardiovascular risk
L. Puiu, A. Didilescu, A. Petrovan, F. Gliga, O. Fira-Mladinescu, E. Dantes, M. Marc, F. Mihaltan (Baia-Mare,, Bucharest, Cluj-Napoca, Targu-Mures, Timisoara, Constanta, Romania)
| |
Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA)
A. Czyzak-Gradkowska, A. Nowinski, R. Plywaczewski, L. Jonczak, M. Targowska, P. Sliwinski, D. Gorecka (Warsaw, Poland)
| |